title: [Assessment of plasma endothelin level measurement in systemic sclerosis].
abstract: OBJECTIVE
  According to current knowledge, endothelin (ET)-1 plays an important role in the pathogenesis of systemic sclerosis (SSc). We assessed ET plasma levels in SSc patients according to the clinical presentation and the presence of complications such as pulmonary arterial hypertension (PAH).
  
  
  METHODS
  Sixty-three consecutive patients with SSc were included. The control group included 17 healthy patients. ET plasma level was determined for all patients. Pulmonary function test and pulmonary high resolution computed tomography were performed in 44 patients and echocardiography in 51 patients, to screen for PAH, always confirmed by a right heart catheterization.
  
  
  RESULTS
  ET plasmatic levels were higher in SSc patients than in healthy group subjects but the difference was not significant (3.72+/-1.13 vs 3.40+/-0.71 pmol/l, p=0.27). ET plasmatic levels were significantly higher in patients with PAH than in patients without PAH (4.28+/-0.65 vs 3.62+/-1.07 pmol/l, p=0.04) and in patients with anticentromere antibodies (3.96+/-1.11 vs 3.19+/-1.12 pmol/l, p=0.03). There was a positive linear correlation between ET plasmatic levels and systolic pulmonary arterial pressure (r=0.34, p=0.013). The best cut-off value for ET plasmatic level to discriminate patients affected by PAH was determined by ROC curve method: 4.1 pmol/l (sensibility 85.7%, specificity 66%).
  
  
  CONCLUSIONS
  ET plasmatic levels were higher in SSc patients affected by PAH and patients with anticentromere antibodies. There was a positive linear correlation between ET plasmatic levels and systolic pulmonary arterial pressure. Assessment of ET plasmatic levels for detection and monitoring of pulmonary hypertension during SSc is warranted in larger prospective studies.
authors.affiliation: Service de Médecine Interne, Centre National de Référence des Atteintes Vasculaires de la Sclérodermie, Hôpital Claude-Huriez, CHRU de Lille, Université Lille-II, rue Michel-Polonovski, 59037 Lille cedex, France.
authors.forename: J
authors.initials: J
authors.lastname: Schmidt
authors.forename: D
authors.initials: D
authors.lastname: Launay
authors.forename: B
authors.initials: B
authors.lastname: Soudan
authors.forename: E
authors.initials: E
authors.lastname: Hachulla
authors.forename: P
authors.initials: P
authors.lastname: de Groote
authors.forename: M
authors.initials: M
authors.lastname: Lambert
authors.forename: V
authors.initials: V
authors.lastname: Queyrel
authors.forename: S
authors.initials: S
authors.lastname: Morell-Dubois
authors.forename: P-Y
authors.initials: PY
authors.lastname: Hatron
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D006328:Cardiac Catheterization; D004452:Echocardiography; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012372:ROC Curve; D011859:Radiography; D012016:Reference Values; D012594:Scleroderma, Localized / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood* / Q000000981:diagnostic imaging
chemical_list: D015415:Biomarkers; D019332:Endothelin-1